Palbocicilib is the generic version of Ibrance. It is taken to prevent the growth of cancer cells, especially for breast cancers. Palbocicilib is used as a targeted therapy. The medicine is used in combination with letrozole to treat locally advanced or secondary breast cancer.That is women suffering from oestrogen receptor positive (ER+) and HER2 negative.
It is taken to prevent the growth of cancer cells, especially for breast cancers.
Palbocicilib is used as a targeted therapy.
The medicine is used in combination with letrozole to treat locally advanced or secondary breast cancer.That is women suffering from oestrogen receptor positive (ER+) and HER2 negative.